Next Generation Sequencing Market Outlook
- 5 years ago
Access full Research:
https://www.renub.com/next-generation-sequencing-market-p.php
Get Free Customization in This Report
Next Generation Sequencing (NGS) is a recent technology in which billions of DNA strands can be sequenced through massive parallel sequencing. The Next-Generation Sequencing has revolutionized the biological study, with its ultra-high throughput, speed and scalability; it has enabled professionals to perform a wide variety of applications and study biological systems at a level which have never been possible before. The NGS technology is also referred as High Throughput Sequencing. This technique minimizes the necessity for fragment-cloning methods used in Sanger sequencing of genomes. The NGS offers rapid speed, low cost, high accuracy, and accurate result even with the low sample input. The use of NGS in clinical diagnostic is one of the major factors for future growth of NGS. Next Generation Sequencing Market is expected to surpass US$ 30 Billion by the end of year 2025 with double digit CAGR during 2019-2025.
Next Generation Sequencing has the possibility to accelerate the early finding of the ailments and the recognition of pharmacogenetics markers to customize its treatments. Today, in the field of medical science, a lot of various technological advancements are going at a rapid pace and that has led to the development of a specific medicine. As a result, the development of custom made medicine has opened an enormous opportunities for the application of next generation sequencing, which could help NGS market to grow significantly over the forecast period.
Renub Research report titled “Next Generation Sequencing Market, Global NGS Forecast by End User (Academic Research, Healthcare, Biotech / Pharma, Government, Others) Type of Test (Targeted Re-sequencing (TPS/WES), RNA-Sequencing, Whole Genome Sequencing, ChIP-Sequencing, De Novo Sequencing, Methyl-Sequencing) Disease (Reproductive Health, Rare Disease Diagnostics, Oncology (Cancer), Metabolic Immune (Diagnostic), Cardiovascular, Others) Informatics (NGS Informatics Services, Primary and Secondary Data Analysis Tools, Storage, Computing, Biological Interpretation and Reporting Tools, LIMS Laboratory Information Management System), Reimbursement, Company Analysis (Illumina, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore Technologies, Roche), Platform, Consumable" provides a complete analysis of global Next Generation Sequencing (NGS) Market.
Contact Us
Email: info@renub.com
Phone: +1-678-302-0700
Web: www.renub.com
https://www.renub.com/next-generation-sequencing-market-p.php
Get Free Customization in This Report
Next Generation Sequencing (NGS) is a recent technology in which billions of DNA strands can be sequenced through massive parallel sequencing. The Next-Generation Sequencing has revolutionized the biological study, with its ultra-high throughput, speed and scalability; it has enabled professionals to perform a wide variety of applications and study biological systems at a level which have never been possible before. The NGS technology is also referred as High Throughput Sequencing. This technique minimizes the necessity for fragment-cloning methods used in Sanger sequencing of genomes. The NGS offers rapid speed, low cost, high accuracy, and accurate result even with the low sample input. The use of NGS in clinical diagnostic is one of the major factors for future growth of NGS. Next Generation Sequencing Market is expected to surpass US$ 30 Billion by the end of year 2025 with double digit CAGR during 2019-2025.
Next Generation Sequencing has the possibility to accelerate the early finding of the ailments and the recognition of pharmacogenetics markers to customize its treatments. Today, in the field of medical science, a lot of various technological advancements are going at a rapid pace and that has led to the development of a specific medicine. As a result, the development of custom made medicine has opened an enormous opportunities for the application of next generation sequencing, which could help NGS market to grow significantly over the forecast period.
Renub Research report titled “Next Generation Sequencing Market, Global NGS Forecast by End User (Academic Research, Healthcare, Biotech / Pharma, Government, Others) Type of Test (Targeted Re-sequencing (TPS/WES), RNA-Sequencing, Whole Genome Sequencing, ChIP-Sequencing, De Novo Sequencing, Methyl-Sequencing) Disease (Reproductive Health, Rare Disease Diagnostics, Oncology (Cancer), Metabolic Immune (Diagnostic), Cardiovascular, Others) Informatics (NGS Informatics Services, Primary and Secondary Data Analysis Tools, Storage, Computing, Biological Interpretation and Reporting Tools, LIMS Laboratory Information Management System), Reimbursement, Company Analysis (Illumina, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore Technologies, Roche), Platform, Consumable" provides a complete analysis of global Next Generation Sequencing (NGS) Market.
Contact Us
Email: info@renub.com
Phone: +1-678-302-0700
Web: www.renub.com